Physician profile
Gagan D Singh
NPI 1932356771
$1,215,574.46
in general payments reported to CMS, 2019-2025
23 companies · $149K in 2025
The $149K reported for 2025 was more than what 99% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $177K · 2020: $67K · 2021: $140K · 2022: $268K · 2023: $241K · 2024: $174K · 2025: $149K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $349K · Travel and Lodging: $99K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $94K · Food and Beverage: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $3,250 · Grant: $195.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $348,540.77 |
| Travel and Lodging | $98,824.90 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $94,125.00 |
| Food and Beverage | $19,331.30 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $3,250.00 |
| Grant | $195.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $429,500.23 | 2019-2025 | Mitraclip, Triclip, Navitor |
| W. L. Gore & Associates, INC. | $362,097.76 | 2019-2025 | Product In Development, Gore Cardioform Septal Occluder |
| Philips North America LLC | $209,937.22 | 2019-2025 | (9520) Igt Devices Undivided, Igt Devices Undivided, Ice 3d |
| Boston Scientific Corporation | $115,575.69 | 2019-2025 | Watchman Access System, Versacross Access Solution, Watchman Flx |
| Baylis Medical Company INC | $30,000.00 | 2019-2021 | |
| Siemens Medical Solutions USA, INC. | $28,358.01 | 2020-2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $18,914.31 | 2019-2025 | Lifevest |
| Renalpro Medical INC. | $13,850.00 | 2021 | |
| Edwards Lifesciences Corporation | $2,516.73 | 2021-2025 | Sapien 3 Ultra Resilia, Pascal, Evoque |
| Medtronic, INC. | $1,540.11 | 2021-2025 | Corevalve Evolut R |
| Biosense Webster, INC. | $1,250.00 | 2024 | Carto 3 |
| Biotronik INC. | $896.03 | 2019-2022 | |
| Abiomed | $280.63 | 2020-2025 | Impella |
| Medtronic Vascular, INC. | $244.02 | 2019 | |
| Shockwave Medical, INC | $175.73 | 2021-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiovascular Systems INC. | $134.65 | 2020 | |
| Recor Medical INC | $114.83 | 2024 | Paradise Renal Denervation System |
| Asahi Intecc USA, INC. | $100.00 | 2020 | |
| Pfizer INC. | $28.94 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.00 | 2020 | |
| Sanofi-Aventis U.S. LLC | $22.14 | 2019 | |
| Cathworks, INC. | $14.43 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gagan Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.